ALTOSTAR
LIVE

Serial Number

79183877

Owner

altona Diagnostics GmbH

Attorney

Matthew J. Smith

Filing Date

Oct 6, 2015

Add to watchlist:

No watchlists yet
View on USPTO

ALTOSTAR Trademark

Serial Number: 79183877 • Registration: 5547717

ALTOSTAR is a trademark filed by altona Diagnostics GmbH on October 6, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

altona Diagnostics GmbH (6 trademarks)

Mörkenstraße 12

Entity Type: 99

Trademark Details

Filing Date

October 6, 2015

Registration Date

August 28, 2018

Published for Opposition

March 13, 2018

Goods & Services

Scientific apparatus and instruments for laboratory use and for the conducting and evaluation of diagnostic examinations for medical purposes, namely, fluid handling devices, pipetting workstation, sensing and signaling devices for measurement and quality control of materials processing by laser; medical laboratory research instruments for DNA analysis, and RNA analysis; data processing apparatus and parts thereof namely, electronic systems comprising fluid handlers, plate readers, vial readers, bar code reader, control software designed for isolation and purification of nucleic acids, set up reaction mixes for polymerase chain reaction (PCR) and PCR thermal cyclers; computer software programs for controlling laboratory equipment for the isolation and purification of nucleic acids; computer software for use in vitro diagnostic or scientific research, specifically for controlling diagnostic apparatus in the nature of electronic systems comprising fluid handlers, plate readers, vial readers and bar code readers used for isolation and purification of nucleic acids, set up reaction mixes for polymerase chain reaction (PCR) and PCR thermal cyclers

Pharmaceutical and veterinary preparations namely biological substances and chemical preparations for use in diagnosing and monitoring of infectious diseases; in vitro diagnostic preparations for medical purposes; in vitro diagnostic test reagents and control standards, namely reference standards in the nature of pure materials being synthetic DNA, olionnucleotides, genomic DNA and tissue used as a measurement base for similar substances, all for medical diagnostic use or veterinary use; diagnostic preparations for clinical and medical use; diagnostic reagents for use in identifying pathogens for clinical and medical use; diagnostic kits consisting primarily of diagnostic reagents for use in identifying pathogens for clinical and medical use

Biological preparations for use in laboratory research for sample preparation and pathogen detection other than for medical or veterinary use; biological substances and chemical preparations, namely reagents for isolation and purification of nucleic acids, in vitro diagnostic test reagents, and control standards, namely reference standards in the nature of pure chemicals used as a measurement base for similar substances, all for scientific and research purposes; diagnostic reagents for use in identifying pathogens for scientific and research use; diagnostic kits consisting primarily of diagnostic reagents for use in identifying pathogens for scientific and research use; chemical substances for analysis in scientific and laboratory research, other than for medical or veterinary purposes; chemicals for use in industry

Scientific research, in the fields of biology, chemistry and medicine ; Scientific and technological services, namely, technical research, and scientific research in the field of molecular biology; development of computer hardware and software, in the fields of biology, chemistry and medicine; consultancy services for scientific purposes, namely, consulting in the fields of biotechnology, laboratory testing, and diagnostics; technological laboratory consultancy services, namely, consulting in the field of laboratory testing, scientific laboratories, and medical laboratories; clinical research and medical laboratory services; medical research; biochemical research and development

Filing History

INTERNATIONAL REGISTRATION RENEWED
Sep 4, 2025 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 6, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 6, 2025 C75A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 20, 2025 EROP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 19, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 19, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 19, 2025 REAP
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Jan 7, 2025 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 6, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Jun 17, 2024 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Jan 27, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 28, 2023 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 22, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 22, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2021 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 12, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 12, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 28, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 28, 2018 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 22, 2018 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Jun 19, 2018 CHPB
ASSIGNED TO PETITION STAFF
Jun 15, 2018 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 23, 2018 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 29, 2018 ETOF
NOTIFICATION PROCESSED BY IB
Mar 16, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 13, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 21, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 30, 2018 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jan 4, 2018 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Jan 4, 2018 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Jan 4, 2018 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 10, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 10, 2017 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 25, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 9, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 9, 2017 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 16, 2017 GNFN
FINAL REFUSAL E-MAILED
May 16, 2017 GNFR
FINAL REFUSAL WRITTEN
May 16, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 20, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 20, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 20, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2016 TROA
REFUSAL PROCESSED BY IB
May 14, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 21, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 21, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 18, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 15, 2016 MAFR
ASSIGNED TO EXAMINER
Mar 10, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 3, 2016 REPR